|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.13 USD | +0.27% |
|
-.--% | - |
| 28/07/25 | Verve Therapeutics, Inc.(NasdaqGS:VERV) dropped from S&P Biotechnology Select Industry Index | CI |
| 28/07/25 | Verve Therapeutics, Inc.(NasdaqGS:VERV) dropped from S&P Global BMI Index | CI |
| Market Cap | 994M 859M 791M 741M 1.39B 94.49B 1.41B 9.34B 3.64B 45.99B 3.73B 3.65B 159B | P/E Ratio 2023 |
-4.47x | P/E Ratio 2024 | -2.4x |
|---|---|---|---|---|---|
| Enterprise Value | 540M 466M 430M 402M 754M 51.31B 765M 5.07B 1.98B 24.98B 2.03B 1.98B 86.48B | EV / Sales 2023 |
46,430,598x | EV / Sales 2024 | 717,743x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
Last Transcript: VERE THER
| 1 day | +0.27% |
| 1 year | 5.88 |  | 11.4 |
| 3 years | 2.86 | | 21.42 |
| 5 years | 2.86 | | 78 |
| 10 years | 2.86 | | 78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Haug
PSD | President | - | 24/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/07/25 | Tender | Chief Financial Officer | 1,079,102 | 1.2746% | ||
| 24/07/25 | Issuer sale | Director | 178,339 | 0.2106% | ||
| 24/07/25 | Tender | Founder | 649,863 | 0.7676% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 11.76 10.16 9.36 8.76 16.42 1.12K 16.67 110.5 43.08 543.98 44.13 43.19 1.88K | 32.33 27.93 25.73 24.09 45.14 3.07K 45.84 303.85 118.47 1.5K 121.34 118.76 5.18K |
| Net income | -200M -173M -159M -149M -279M -19.02B -284M -1.88B -733M -9.26B -751M -735M -32.05B | -199M -172M -158M -148M -277M -18.89B -282M -1.87B -728M -9.19B -746M -730M -31.83B |
| Net Debt | -549M -474M -437M -409M -767M -52.19B -778M -5.16B -2.01B -25.4B -2.06B -2.02B -87.95B | -454M -392M -362M -338M -634M -43.18B -644M -4.27B -1.66B -21.02B -1.7B -1.67B -72.77B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- VERV Stock
Select your edition
All financial news and data tailored to specific country editions
